Zobrazeno 1 - 10
of 470
pro vyhledávání: '"Llovet, Jm"'
Autor:
Torrens, L, Abril-Fornaguera, J, Carrillo, J, Balaseviciute, U, Rialdi, A, Haber, P, Montironi, C, Akers, N, Willoughby, CE, Torres-Martin, M, Puigvehi, M, Pinyol, R, Royo, L, Domingo-Sabat, M, Alvaro, DR, Cairo, S, Buendia, MA, Mazzaferro, V, Losic, B, Guccione, E, Sia, D, Armengol, C, Llovet, JM
Publikováno v:
Journal of Hepatology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::953196ecd629905fc4700d2138765c7c
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1934
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1934
Autor:
Torrens, L, Montironi, C, Haber, P, Kuchuk, O, Akers, N, Simon-Coma, M, Nonell, L, Carrillo, J, Cairo, S, Buendia, A, Royo, L, Mazzaferro, V, Losic, B, Sia, D, Armengol, C, Llovet, JM
Publikováno v:
Hepatology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f7cce9e54519a4ff4b861d03f5936e76
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2822
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2822
Publikováno v:
Lancet. 12/6/2003, Vol. 362 Issue 9399, p1907-1917. 11p.
Autor:
Forner A, Reig M, Varela M, Burrel M, Feliu J, Briceno J, Sastre J, Marti-Bonmati L, Llovet JM, Bilbao JI, Sangro B, Pardo F, Ayuso C, Bru C, Tabernero J, Bruix J
Publikováno v:
MEDICINA CLINICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Hepatocellular carcinoma is the most common primary malignancy of the liver and one of the most frequent causes of death in patients with liver cirrhosis. Simultaneously with the recognition of the clinical relevance of this neoplasm, in recent years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9a8eed8b938329408abbf77cb722e615
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9904
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9904
Autor:
Llovet JM, Ducreux M, Lencioni R, Di Bisceglie AM, Galle PR, Dufour JF, Greten TF, Raymond E, Roskams T, De Baere T, Mazzaferro V, Bruix J, Colombo M, Zhu A., BERNARDI, MAURO
Publikováno v:
European journal of cancer (Oxford, England : 1990). 48(5)
EASL–EORTC Clinical Practice Guidelines (CPG) on the manage- ment of hepatocellular carcinoma (HCC) define the use of surveil- lance, diagnosis, and therapeutic strategies recommended for patients with this type of cancer. This is the first Europea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07c435158e2096fc31ef6e3f2cd7231
https://pubmed.ncbi.nlm.nih.gov/22424278
https://pubmed.ncbi.nlm.nih.gov/22424278
Autor:
European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer Llovet JM, Ducreux, M, Lencioni, RICCARDO ANTONIO, Di Bisceglie AM, Galle, Pr, Dufour, Jf, Greten, Tf, Raymond, E, Roskams, T, De Baere, T, Mazzaferro, V, Bernardi, M, Bruix, J, Colombo, M, Zhu, A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3728::f4ef5143837883bb7d155ed104aad772
http://hdl.handle.net/11568/188579
http://hdl.handle.net/11568/188579
Autor:
Llovet, Jm, De Grève, Jacques
PURPOSE: Validated biomarkers of prognosis and response to drug have not been identified for patients with hepatocellular carcinoma (HCC). One of the objectives of the phase III, randomized, controlled Sorafenib HCC Assessment Randomized Protocol (SH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::023564088801fc62fc7f065e7114a999
https://biblio.vub.ac.be/vubir/plasma-biomarkers-as-predictors-of-outcome-in-patients-with-advanced-hepatocellular-carcinoma(486bfae5-a65d-44ee-a9d8-33eef7adbcb2).html
https://biblio.vub.ac.be/vubir/plasma-biomarkers-as-predictors-of-outcome-in-patients-with-advanced-hepatocellular-carcinoma(486bfae5-a65d-44ee-a9d8-33eef7adbcb2).html
Autor:
Mazzaferro, V, Llovet, Jm, Miceli, R, Bhoori, S, Schiavo, M, Mariani, L, Camerini, T, Roayaie, S, Schwartz, Me, Grazi, Gl, Adam, R, Neuhaus, P, Salizzoni, M, Bruix, J, Forner, A, De Carlis, L, Cillo, U, Burroughs, Ak, Troisi, R, Rossi, M, Gerunda, Ge, Lerut, J, Belghiti, J, Boin, I, Gugenheim, J, Rochling, F, Van Hoek, B, Majno, P, Graziadei, I, Vogel, W, Lucidi, V, de Hemptinne, B, Leopardi, L, Cotsoglou, C, Iannelli, A, Staccini, A, Koenigsrainer, A, Steurer, W, Cautero, N, Risaliti, A, Lupo, L, Colledan, M, De Giorgio, M, Fagiuoli, S, Pinna, Ad, Ravaioli, M, Battiston, C, Coppa, J, Regalia, E, Romito, R, Giacomoni, A, Mangoni, J, Maggi, U, Rossi, G, Masetti, M, Montalti, R, Calise, F, Cuomo, O, Scuderi, E, Bridda, A, Vitale, A, Tisone, G, Berloco, P, Paraluppi, G, Patrono, D, Adani, Gl, Baccarani, U, Lorenzin, D, Zieniewicz, K, Ribeiro, V, Soderdahl, G, Giostra, E, Mentha, G, Morel, P, Marelli, L, Patch, D, Muiesan, P, Heaton, N, Schwartz, M, Rossaro, L, Khatri, V, Hsieh, Cb.
Publikováno v:
The Lancet Oncology, Vol. 10, No 1 (2009) pp. 35-43
Background: Patients undergoing liver transplantation for hepatocellular carcinoma within the Milan criteria (single tumour ≤5 cm in size or ≤3 tumours each ≤3 cm in size, and no macrovascular invasion) have an excellent outcome. However, survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b1d50e16a9afcbfc4b8fa1bf21b35d2
https://hdl.handle.net/11380/1064499
https://hdl.handle.net/11380/1064499
BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::1db9026c2d013bc62a52b9ee1cfab2a7
https://biblio.vub.ac.be/vubir/sorafenib-in-advanced-hepatocellular-carcinoma(d86456b8-f3ce-4f7f-97ed-3ca1a5d63de1).html
https://biblio.vub.ac.be/vubir/sorafenib-in-advanced-hepatocellular-carcinoma(d86456b8-f3ce-4f7f-97ed-3ca1a5d63de1).html